2022 Cardiovascular Imaging Innovation 
DAIC
JULY 18, 2024
Circle Cardiovascular Imaging has announced that Erkan Akyuz has been appointed Chief Executive Officer to succeed Circle co-founder and CEO Greg Ogrodnick. The announcement from the company, based in Canadian and founded in 2007, offered that Akyuz is joining Circle during a period of accelerated growth and product innovation.
DAIC
MAY 14, 2024
We’re excited to collaborate with Medis Medical Imaging to add innovative, non-invasive, image-based QFR to our portfolio of offerings around our Allia IGS platform to streamline the experience for clinicians and help us to deliver on our vision for the future image-guided therapy.” Leon, Shubin Qiao, Gregg W.
CardiacWire
MAY 18, 2024
The FDA published its latest Healthcare AI Database last week, featuring a massive 882 AI-enabled medical device clearances, and highlighting some interesting trends in cardiovascular AI. Cardiovascular AI actually makes up a larger 17.4% in 2020-2022, and 13.5% FFRCT, coronary plaque, etc). since the start of 2023.
DAIC
FEBRUARY 13, 2024
25, 2024 in the European Heart Journal Cardiovascular Imaging. 25, 2024 in the European Heart Journal Cardiovascular Imaging 1. 25, 2024 in the European Heart Journal Cardiovascular Imaging 1. Presented at the European Association of Cardiovascular Imaging: Late Breaking Clinical Research and Trials.
CardiacWire
AUGUST 9, 2024
Cardiovascular AI maintained a distant second largest share of FDA-cleared AI products in H1 2024, with 9% of total clearances (10 devices), well below radiology’s 73% share (78 devices). FFRCT, coronary plaque, echo AI, etc)… We’re using this broader definition of cardio AI through the rest of this story.
Expert insights. Personalized for you.
105 
Let's personalize your content